Baroda BNP Paribas Health & Wellness Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Baroda BNP Paribas Health & Wellness Growth Direct Plan

NAV
₹9.6389
-1.13%
(8 Aug)
AUM
631 Cr
Risk
Very High Risk
Insights
No insights found for this fund
Compare with other fund
1Y
+2.3%
-1.2%
-6.7%
-7.6%
NA
3Y
+31.0%
+30.9%
+33.5%
+33.1%
NA
5Y
+30.1%
+35.2%
+31.2%
+29.3%
NA
ALL
+18.1%
+12.9%
+11.8%
+16.8%
-3.6%
VOL
16.3%
21.1%
20.3%
19.8%
10.9%
TER
0.5%
1.1%
0.8%
0.9%
NA
AUM
₹7,200 Cr
₹2,591 Cr
₹5,278 Cr
₹1,439 Cr
₹631 Cr
INFO
1.11
0.61
0.58
0.85
-0.33
See fund holdings as of 30th Jun
Top holdings
Clearing Corporation Of India Ltd
99.6%
Net Receivables / (Payables)
13.6%
Divi's Laboratories Ltd
2.7%
Sun Pharmaceuticals Industries Ltd
1.3%
Fortis Healthcare Ltd
1.3%
Cipla Ltd
1.2%
Laurus Labs Ltd
1.1%
Aster DM Healthcare Ltd Ordinary Shares
0.9%
Torrent Pharmaceuticals Ltd
0.8%
AstraZeneca Pharma India Ltd
0.7%
Top industry exposure
Healthcare
14.0%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
-
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Sanjay Chawla

FAQs